Digital Content 
NEWS #PharmaBuzz
17 May 2024
// FDA
https://www.pharmacompass.com/pdf/news/fda-confirms-para-iv-patent-for-tasimelteon-hetlioz-lq-oral-suspension-24597.pdf
06 Mar 2024
// ENDPTS
https://endpts.com/fda-denies-hearing-to-vanda-on-jet-lag-indication-for-sleep-disorder-drug/
05 Feb 2024
// ENDPTS
https://endpts.com/vanda-takes-issue-with-fdas-relay-of-deficiencies-for-new-hetlioz-indication/
10 May 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-responds-to-ruling-in-hetlioz-anda-appeal-301821307.html
29 Mar 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/vanda-prevails-in-jet-lag-litigation-against-the-fda-301783748.html#:~:text=On%20March%2027%2C%202023%20a,%2C%20Hetlioz%C2%AE%20(tasimelteon).
12 Jan 2023
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211654
Share 